General evaluation of pipotiazine palmitate in hospitalized and open ward patients with functional psychosis.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008728:Methotrimeprazine / Q000627:therapeutic use; D008875:Middle Aged; D010169:Palmitic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000188:drug therapy*; D012737:Sex Factors; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use
D014150:Antipsychotic Agents; D010169:Palmitic Acids; D010880:Piperidines; D013449:Sulfonamides; D008728:Methotrimeprazine